ReneSola Ltd. rallies on upbeat revenue outlook


Chinese solar concern ReneSola Ltd. (NYSE: SOL) is trading sharply higher today after the company reported that fourth-quarter revenue will exceed analysts' expectations. SOL expects to rake in revenue of $157 million to $159 million, compared to the Street's consensus estimate of $154 million.

However, the rest of ReneSola's forecast wasn't quite as sunny. The alternative energy firm warned that it will swing to a fourth-quarter net loss of $125 million to $130 million, prompted by "significant downward pressure" on average selling prices and margins. ReneSola predicted quarterly writedowns of $130 million to $140 million, due to the rapid deterioration in the price and value of materials.

In contrast to its upbeat outlook for the fourth quarter, the solar issue expects fiscal 2009 revenue of $650 million to $700 million, falling short of the average analyst forecast for $759 million. ReneSola is due to report its full fourth-quarter results on March 12.

Investors have reacted enthusiastically today, focusing on the hiked revenue forecast rather than the loss warning. At last check, the American depositary shares were up approximately 10% at $2.43. However, the equity's rally has run into a roadblock in the form of SOL's descending 10-day moving average. It's one of just many trendlines looming overhead; the stock has dropped 77.5% during the past year, and is currently re-testing its November 2008 lows near the 2 level.

Despite this poor price action, Wall Street continues to harbor high hopes for SOL. Thomson Reuters reports that the average 12-month price target for the shares is $4.19, implying a premium of nearly 90% from Monday's closing price. Option players harbor similarly lofty ambitions for SOL -- peak call open interest is docked at the 5 strike in the March series, and at the 7.50 strike in the April series.

Of course, it's natural that calls will outnumber puts once a stock has slipped so low on the charts, since there are no out-of-the-money put options in play. Nevertheless, the optimism among analysts and investors is troubling, considering SOL's weak technical performance. Once today's enthusiasm wanes, traders might finally take note of the company's sizable writedowns and sketchy revenue outlook for 2009. If the widespread bullish sentiment toward the stock starts to unwind, SOL will likely be smacked with fresh selling pressure.

Elizabeth Harrow is an analyst and financial writer in the research department at Schaeffer's Investment Research. She is featured in the video series Schaeffer's Daily Q&A on SchaeffersResearch.com.

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 05:04 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1329127472836 ms.